(Q37109731)

18 August 2017

Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia (English)

1 reference

18 August 2017

Efficacy and Safety of 6-Month Nightly Ramelteon Administration in Adults with Chronic Primary Insomnia (English)

0 references

0 references

1 reference

Markku Partinen

6

0 references

author name string

Geert Mayer

1

1 reference

18 August 2017

Sherry Wang-Weigand

2

1 reference

18 August 2017

Barbara Roth-Schechter

3

1 reference

18 August 2017

Reiner Lehmann

4

1 reference

18 August 2017

Corinne Staner

5

1 reference

18 August 2017

Markku Partinen

6

1 reference

18 August 2017

GeertSherry Wang-Weigand

2

0 references

publication date

1 March 2009

1 reference

18 August 2017

March 2009

0 references

published in

Sleep

1 reference

18 August 2017

32

1 reference

18 August 2017

3

1 reference

18 August 2017

351-360

1 reference

Circadian phase-shifting effects of repeated ramelteon administration in healthy adults

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Melatonin receptors: role on sleep and circadian rhythm regulation

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Relationship between reported and measured sleep times: the sleep heart health study (SHHS).

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

A systematic review of valerian as a sleep aid: safe but not effective

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

The nature and power of the placebo effect

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Prevalence, associated risks, and treatment patterns of insomnia.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

The human circadian system in normal and disordered sleep.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

A review of the evidence for the efficacy and safety of trazodone in insomnia

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Determination of the minimal clinically significant difference on a patient visual analog sleep quality scale

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Targeted disruption of the mouse Mel(1b) melatonin receptor

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Mammalian melatonin receptors: molecular biology and signal transduction.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Zaleplon and triazolam in humans: acute behavioral effects and abuse potential

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Selective effects of zolpidem on human memory functions

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Acute, subchronic and discontinuation effects of zopiclone on sleep EEG and nocturnal melatonin secretion

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Memory, benzodiazepines, and anxiety: integration of theoretical and clinical perspectives.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Melatonin shifts human circadian rhythms according to a phase-response curve

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

A meta-analysis of sleep changes associated with placebo in hypnotic clinical trials.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Phase shifting the human circadian clock using melatonin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

An internet-based randomized, placebo-controlled trial of kava and valerian for anxiety and insomnia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Reliability, validity, and clinical application of the Visual Analogue Mood Scale.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

An international survey of insomnia: under-recognition and under-treatment of a polysymptomatic condition

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Cognitive performance and sleep quality in the elderly suffering from chronic insomnia. Relationship between objective and subjective measures

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Subjective estimates of sleep differ from polysomnographic measurements in obstructive sleep apnea patients.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Sedative, memory, and performance effects of hypnotics

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

The distribution and clinical significance of sleep time misperceptions among insomniacs.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647789

Visual analogue scales: measurement of subjective phenomena

3 September 2018

1 reference

12 December 2020

The Benzodiazepine Withdrawal Symptom Questionnaire

1 reference

12 December 2020

Eszopiclone (Lunesta), a new hypnotic

1 reference

12 December 2020

Ambien CR for insomnia

1 reference

12 December 2020

NIH State-of-the-Science Conference Statement on manifestations and management of chronic insomnia in adults

1 reference

12 December 2020

Identifiers

DOI

10.1093/SLEEP/32.3.351

0 references

1 reference

18 August 2017

PubMed publication ID

19294955

1 reference